[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Vaccines and genetics", "description": "Australian vaccine\n\nhttps://www.smh.com.au/politics/federal/australian-covid-vaccine-terminated-due-to-hiv-false-positives-20201210-p56mju.html?utm_source=Nature+Briefing&utm_campaign=dd61a8472e-briefing-dy-20201211&utm_medium=email&utm_term=0_c9dfd39373-dd61a8472e-44762053\n\nUniversity of Queensland\n\nFifty million doses ordered by government\n\n200 volunteers in two groups\n\nAged 18 to 55, and 56 and over, placebo\n\nPhase one trial\n\nSafe and said it produced a strong immune response \n\nTrial terminated; $ 4.5 m (US) lost\n\nSeveral participants, false positive HIV test results\n\nNo health risks\n\n20 million new doses from Oxford University-AstraZeneca and another 11 million from Novavax\n\nUS rollout\n\nGeneral Gustave Perna\n\nFactory, Kalamazoo, Michigan\n\nFlight and road\n\n-70 degrees Celsius (-94F)\n\nFirst doses of vaccine arriving at 145 sites Monday\n\nTuesday, 425 sites\n\nWednesday, 66 sites\n\nHalf of 6.4 million doses sent out\n\nPfizer, 50 million in 2020, half to the US\n\nUS, 100 million doses\n\nApproved for 16 years and older\n\nMassachusetts-based Moderna, increasing vaccinations to 20 million Americans in 2020\n\nFollowed by 200 million Moderna doses\n\nEveryone by June 2021\n\nChina vaccine\n\nInactivated\n\nhttps://www.bbc.co.uk/news/world-asia-china-55212787\n\nSinovac, Beijing, CoronaVac\n\nArrived in Indonesia, (Turkey, Brazil, Chile)\n\nAnother 1.8 m doses due to arrive by January\n\nFridge temperatures\n\nPhase 3 results 15th December\n\nProduction 300 m per year\n\nAfrican continent, $2bn\n\nLatin American and Caribbean, $1bn\n\nCost?\n\nModerna, 500 million doses in 2021\n\nAstraZeneca, 700 million doses by April\n\nUK, Christmas five-day relaxation period\n\nhttps://www.bbc.co.uk/news/uk-wales-55279371\n\nTravel from high to low risk areas\n\nUp to three households can stay together, \"Christmas bubble\" from 23 to 27 December\n\nAll four UK nations\n\nGenetic predisposition\n\nhttps://www.bbc.co.uk/news/health-54832563\n\nGenetic mechanisms of critical illness in Covid-19 Nature, Edinburgh)\n\nhttps://www.nature.com/articles/s41586-020-03065-y\n\nSusceptibility to viral infection\n\nPropensity to develop harmful pulmonary inflammation.\n\nGenetic factors in:\n\nSusceptibility to life threatening infections\n\nImmune-mediated diseases\n\nHost genetic variants\n\nGenome-wide association study\n\nN = 2, 244 critically ill Covid-19 patients\n\nFrom 208 UK intensive care units\n\nGenome-wide significant associations\n\nPotential for repurposing of licensed medications\n\nAssociations with severe COVID\n\nLow expression of IFNAR2 (Chromosome 21)\n\nResults in lower production of interferon\n\nAccounted for nearly 15% of critical Covid-19 cases\n\nInterferons interfere with viral replication\n\nProduce antiviral enzymes to prevent viral replication\n\nInhibit protein synthesis\n\nStimulate local immune cells\n\nCause fever, muscle aches and general malaise\n\nInterferon would need to be given early\n\nWHO SOLIDARITY trial\n\nhttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments\n\nInterferon had little or no effect on overall mortality, initiation of ventilation and duration of hospital stay in hospitalized patients\n\nNebulised interferon beta-1a for patients with COVID-19 (12th November)\n\nhttps://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30523-3/fulltext\n\nHigh expression of TYK2 (Chromosome 19)\n\nUp regulation of inflammation\n\nRheumatoid arthritis drug, Baricitinib targets this biological mechanism\n\nLarge-scale randomised clinical trials will be essential", "link": "https://www.youtube.com/watch?v=2lA5_WxP5nQ", "date_published": "2020-12-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]